|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
1
|
Resverlogix Corp.
|
Sep 10, 2018 07:50AM
|
|
Re: Report of exempt distribution
|
1
|
Resverlogix Corp.
|
Nov 10, 2020 08:12PM
|
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 03:21PM
|
|
Re: Reaching 250 MACE
|
1
|
Resverlogix Corp.
|
Apr 23, 2019 11:10AM
|
|
Re: Rough Transcript - Resverlogix Corporate Update and Conference Call - 06/10/2020
|
1
|
Resverlogix Corp.
|
Jun 11, 2020 01:54PM
|
|
Re: No ESC 2019 Late Breaker
|
1
|
Resverlogix Corp.
|
Jul 02, 2019 08:33AM
|
|
Re: Warrants are getting pounded
|
1
|
Resverlogix Corp.
|
Dec 16, 2019 02:30PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 09:57PM
|
|
supply vs demand
|
1
|
Resverlogix Corp.
|
May 28, 2020 03:52PM
|
|
Re: Is there anything that can/will save these June warrants?
|
1
|
Resverlogix Corp.
|
May 25, 2021 11:39AM
|
|
Re: Some Thoughts -operational funding
|
1
|
Resverlogix Corp.
|
Jan 17, 2020 06:45PM
|
|
Re: Pretty much every day...
|
1
|
Resverlogix Corp.
|
Jan 21, 2020 10:18AM
|
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
1
|
Zenith Epigenetics
|
Oct 28, 2023 04:13PM
|
|
Re: is the latest short # out yet?
|
1
|
Resverlogix Corp.
|
Jun 05, 2020 10:58AM
|
|
Re: Fair warning to everyone here....
|
1
|
Resverlogix Corp.
|
Jun 24, 2019 10:16PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
1
|
Resverlogix Corp.
|
Apr 12, 2021 06:32PM
|
|
Re: Price for Phase 1 Alz drug
|
1
|
Resverlogix Corp.
|
Jan 14, 2020 08:53AM
|
|
Re: BIO CEO Slides Up
|
1
|
Resverlogix Corp.
|
Feb 13, 2019 12:00PM
|
|
Re: Gonna check back for the last 15 mintues....
|
1
|
Resverlogix Corp.
|
Apr 09, 2019 10:49AM
|
|
Re: Also interesting, but less encouraging
|
1
|
Resverlogix Corp.
|
Aug 06, 2022 10:41AM
|
